Articles

1. Anticipating Success: Meeting The Inherent Challenges Of Complex Drug Substances 9/17/2013

   Realizing the full potential of a novel injectable drug compound is no small task. In the months and years that lead from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can slow development to a halt, often at key stages.

2. Kemwell Overview 3/29/2012
   Manufacturing customers include top pharmaceutical companies – Allergan, Bayer, GSK, J&J, Pfizer, Teva, and Novartis, as well as small emerging biotech.